本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cartesian Therapeutics

5.85
-0.2300-3.78%
盤後5.850.00000.00%16:18 EDT
成交量:32.17萬
成交額:187.47萬
市值:1.55億
市盈率:-1.17
高:6.17
開:6.08
低:5.60
收:6.08
52周最高:15.57
52周最低:5.60
股本:2,650.90萬
流通股本:979.24萬
量比:2.35
換手率:3.29%
股息:- -
股息率:- -
每股收益(TTM):-5.0200
每股收益(LYR):-4.4814
淨資產收益率:-7029.26%
總資產收益率:-14.82%
市淨率:-1.23
市盈率(LYR):-1.31

資料載入中...

2024/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/15

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/04

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/28

SEC問詢函

Form CORRESP - Correspondence
2024/09/27

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/26

重要事件披露

Form 8-K - Current report
2024/09/23

重要事件披露

Form 8-K - Current report
2024/09/21

SEC問詢函

Form CORRESP - Correspondence
2024/09/20

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/09/10

SEC問詢函

Form CORRESP - Correspondence
2024/09/09

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/02

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933